Back to NATIXIS NATIXIS

XBIXBI
Showing 6 of 16 quarters

Position history for NATIXISNATIXIS's holdings in State Street SPDR SP Biotech ETF

Yes. Natixis holds 492,616 shares of XBI (State Street SPDR SP Biotech ETF), worth $78M, as of its Q2 2026 13F filing. It increased the position by 3,812 shares (+0.8%) from Q1 2026. Natixis has held XBI since Q1 2025, across 6 quarterly 13F filings. XBI is 0.3% of Natixis' reported 13F portfolio.

Current Value

$78M

Current Shares

492,616

Total Value Change

+$37.7M

Total Shares Change

-7,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
492,616
+0.8%
$78M0.3%$158.25
36
2026-Q1
Decreased
488,804
-0.9%
$62.4M0.2%$127.60
0
2025-Q4
Decreased
493,049
-1.0%
$60.1M0.2%$121.81
0
2025-Q3
Decreased
497,896
-0.4%
$49.9M0.2%$99.77
0
2025-Q2
Unchanged
500,000
0.0%
$41.5M0.2%$82.55
0
2025-Q1
New
500,000
-
$40.3M0.2%$80.72
48

Other major holders of XBI: BNP PARIBAS FINANCIAL MARKETS, GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used